You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 121 No. 7, July 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Energy Expenditure in Malnourished Patients With Colorectal Cancer

Daniel T. Dempsey, MD; Linda S. Knox, BSN; James L. Mullen, MD; Clifford Miller, MS; Irene D. Feurer, MS; Gordon P. Buzby, MD

Arch Surg. 1986;121(7):789-795.


Abstract

• To evaluate energy expenditure in patients who have colorectal cancer with varying stages of disease and to examine the possible determinants of energy expenditure in a group of patients with cancer who have the same type of tumor, we studied 73 patients with biopsy proven and pathologically staged adenocarcinomas of the colon and rectum. Resting energy expenditure (REE) was measured by indirect calorimetry and compared with predicted energy expenditure (PEE), which was calculated from the Harris-Benedict formulas. Nutritional and tumor characteristics were examined. Forty-nine percent of patients had abnormal REE (normal=PEE±10%). One quarter of the patients were hypometabolic (REE<90% PEE). The abnormalities persisted despite normalization of REE to metabolic body size (kg0.75) or predicted values based on weight, height, age, and sex. There were no differences in nutritional status, as judged by the percent of weight loss and visceral protein levels, between those patients in the hypometabolic, normometabolic, or hypermetabolic categories, and there were no significant relationships between energy expenditure and the tumor burden. The mean duration of disease in the normometabolic group was 4.5 months, while the hypometabolic and hypermetabolic groups had mean durations of 9.5 and 14.2 months, respectively. The tumor site and duration of the disease are important variables in studies of energy expenditure in patients with cancer.

(Arch Surg 1986;121:789-795)



Author Affiliations

From the Department of Surgery (Drs Dempsey, Mullen, and Buzby), Nutrition Support Service (Mss Knox and Feurer), and Cancer Center (Mr Miller), Hospital of the University of Pennsylvania, Philadelphia.


Footnotes

Accepted for publication Oct 10, 1985.

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Standard Equations Are Not Accurate in Assessing Resting Energy Expenditure in Patients With Amyotrophic Lateral Sclerosis
Sherman et al.
JPEN J Parenter Enteral Nutr 2004;28:442-446.
ABSTRACT | FULL TEXT  

Ablation of Abnormal Energy Expenditure by Curative Tumor Resection
Luketich et al.
Arch Surg 1990;125:337-341.
ABSTRACT  

Energy Requirements for Cancer Patients and the Effect of Total Parenteral Nutrition
Merrick et al.
JPEN J Parenter Enteral Nutr 1988;12:8-14.
ABSTRACT  

Tumor Glycolysis-Host Gluconeogenesis in Cancer Cachexia
GOLD
Arch Surg 1987;122:850-850.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.